To determine the effects of acetylcholine on the coronary bed in the baboon and whether the effects preceded or followed the action of acetylcholine on ventricular function, eight adult baboons (Papio anubis) were instrumented to measure left ventricular (LV) and mean arterial pressures, LV dP/dt, regional myocardial function, and coronary blood flow. Acetylcholine was injected locally through a catheter positioned in the coronary artery ostium using fluoroscopic guidance in intact sedated baboons. With heart rate held constant, intracoronary acetylcholine (0.5 jig/kg) reduced coronary blood flow by 82+4% from a baseline value of 34+4 ml/min without a significant change in mean arterial pressure and with a reduction in LV dP/dt of only 12±3%. The decrease in coronary blood flow occurred before either LV dP/dt or regional myocardial function fell in the region of the heart receiving acetylcholine. After the intense coronary constriction, a later phase characterized by dilation was observed. The changes in coronary blood flow with acetylcholine were unaffected by combined a-and 6-adrenoceptor blockades but were abolished by muscarinic blockade. Low doses of acetylcholine elicited only coronary vasodilation. All doses of acetylcholine, administered directly into the iliac artery, also elicited only iliac vasodilation. Intracoronary acetylcholine in conscious dogs also induced only coronary vasodilation, whereas in conscious calves at higher doses, initial vasoconstrictor responses were observed, which also preceded reductions in regional myocardial function. These results suggest that the controversy surrounding the effects of acetylcholine can be reconciled on the basis of species, vascular bed studied, and dose. In the baboon, although lower doses of acetylcholine induce vasodilation, larger doses exert a direct vasoconstrictor effect on the coronary bed via a muscarinic mechanism. (Circulation Research 1991;69:706-713) C holinergic regulation of the coronary circulation remains one of the most intense controversies in coronary physiology. It has been generally accepted that in the canine model, cholinergic activation results in vasodilation of the coronary resistance vesselsl-4 and large coronary arteries.5 However, in other species, including normal human subjects and nonhuman primates, acetylcholine (ACH) has been shown to induce both coronary vasodilation3A46-12 and coronary vasoconstriction.2,3,9-17 Many of the studies have been conducted in isolated tissue,713,16 in acutely prepared, anesthetized animals,3,4,17 or in normal human subjects,6'8-12,14,15 in which measurements are indirect and complications due to latent coronary artery disease might also complicate interpretation.18 Accordingly, the goal of the present study was to determine the coronary vascular effects of intracoronary ACH on the coronary resistance vessels in chronically instrumented, intact, tranquilized baboons. ACH was administered directly into the coronary artery to eliminate the complicating systemic effects of ACH. Increasing doses of ACH were used to determine dose-related effects. Because ACH may also elicit negative inotropic and chronotropic effects,19 heart rate was held constant and regional myocardial function was measured continuously in the distribution of the coronary artery in which ACH was administered. The underlying hypothesis was that if ACH induced primary vasoconstriction, then a decrease in blood flow would precede any decrease in mechanical function; conversely, if ACH induced coronary vasoconstriction secondary to changes in myocardial metabolic demand, then the effects on coronary
To determine the effects of acetylcholine on the coronary bed in the baboon and whether the effects preceded or followed the action of acetylcholine on ventricular function, eight adult baboons (Papio anubis) were instrumented to measure left ventricular (LV) and mean arterial pressures, LV dP/dt, regional myocardial function, and coronary blood flow. Acetylcholine was injected locally through a catheter positioned in the coronary artery ostium using fluoroscopic guidance in intact sedated baboons. With heart rate held constant, intracoronary acetylcholine (0.5 jig/kg) reduced coronary blood flow by 82+4% from a baseline value of 34+4 ml/min without a significant change in mean arterial pressure and with a reduction in LV dP/dt of only 12±3%. The decrease in coronary blood flow occurred before either LV dP/dt or regional myocardial function fell in the region of the heart receiving acetylcholine. After the intense coronary constriction, a later phase characterized by dilation was observed. The changes in coronary blood flow with acetylcholine were unaffected by combined a-and 6-adrenoceptor blockades but were abolished by muscarinic blockade. Low doses of acetylcholine elicited only coronary vasodilation. All doses of acetylcholine, administered directly into the iliac artery, also elicited only iliac vasodilation. Intracoronary acetylcholine in conscious dogs also induced only coronary vasodilation, whereas in conscious calves at higher doses, initial vasoconstrictor responses were observed, which also preceded reductions in regional myocardial function. These results suggest that the controversy surrounding the effects of acetylcholine can be reconciled on the basis of species, vascular bed studied, and dose. In the baboon, although lower doses of acetylcholine induce vasodilation, larger doses exert a direct vasoconstrictor effect on the coronary bed via a muscarinic mechanism. (Circulation Research 1991;69:706-713) C holinergic regulation of the coronary circulation remains one of the most intense controversies in coronary physiology. It has been generally accepted that in the canine model, cholinergic activation results in vasodilation of the coronary resistance vesselsl-4 and large coronary arteries. 5 However, in other species, including normal human subjects and nonhuman primates, acetylcholine (ACH) has been shown to induce both coronary vasodilation3A46-12 and coronary vasoconstriction.2,3,9-17 Many of the studies direct and complications due to latent coronary artery disease might also complicate interpretation.18 Accordingly, the goal of the present study was to determine the coronary vascular effects of intracoronary ACH on the coronary resistance vessels in chronically instrumented, intact, tranquilized baboons. ACH was administered directly into the coronary artery to eliminate the complicating systemic effects of ACH. Increasing doses of ACH were used to determine dose-related effects. Because ACH may also elicit negative inotropic and chronotropic effects,19 heart rate was held constant and regional myocardial function was measured continuously in the distribution of the coronary artery in which ACH was administered. The underlying hypothesis was that if ACH induced primary vasoconstriction, then a decrease in blood flow would precede any decrease in mechanical function; conversely, if ACH induced coronary vasoconstriction secondary to changes in myocardial metabolic demand, then the effects on coronary Knight et al Parasympathetic Coronary Constriction and Dilation 707 blood flow and vascular resistance would follow the effects on mechanical function. To determine if the coronary effects were unique, the effects of ACH, administered directly into the iliac artery, were also examined in conscious baboons. Finally, to further address potential species differences, effects of intracoronary injection of ACH were examined in conscious dogs, in which vasodilation has generally been observed,1,5 and in calves, in which coronary vasoconstriction has been reported in in vitro experiments.2 Materials and Methods Eight male baboons (Papio anubis) weighing 25-35 kg were premedicated with ketamine hydrochloride (8 mg/kg i.m.). General anesthesia was induced with sodium thiopental (2 mg/kg i.v.) and was maintained with halothane (0.5-1.0 vol%). With the use of sterile technique, the chest was opened through a midline sternotomy, the pericardium incised, and the heart exposed. A miniature solid-state pressure gauge (Konigsberg Instruments, Inc., Pasadena, Calif.) was implanted in the left ventricular (LV) chamber. Pacing electrodes were implanted on the right atrium. Heparin-filled Tygon catheters were implanted in the ascending aorta and left atrium. The right coronary artery was carefully dissected, and a lightweight Doppler ultrasonic flow transducer was implanted. In three of these animals, a hydraulic occluder was implanted on the right coronary artery distal to the flow transducer, and ultrasonic segment length gauges were implanted in the right ventricular myocardium in the center of the region supplied by the right coronary artery to measure regional myocardial segment length. In one baboon, a flow transducer and occluder were implanted on the left circumflex coronary artery, and ultrasonic wall thickness gauges were implanted transmurally across the LV free wall in the center of the myocardium supplied by that artery to measure regional myocardial wall thickness. The myocardium supplied by the instrumented coronary artery was identified by occluding the artery for 15 seconds to create a cyanotic area before the ultrasonic crystals were implanted. Placement of the crystals also was verified visually under fluoroscopy by injection of radiopaque dye into the instrumented artery during the experiment, which illuminated the area of myocardium supplied by the coronary artery studied. In four baboons, the iliac artery was instrumented to measure the effects of ACH on iliac blood flow. In these animals, general anesthesia was induced with sodium thiopental (2 mg/kg i.v.) and halothane (0.5-1.0 vol%). With All experiments were performed 2-6 weeks after operations, when the animals had recovered from surgery and no signs of infection were present. On the day of the experiments, the baboons in which coronary blood flow was measured were sedated with ketamine hydrochloride (8-10 mg/kg i.m.) and were placed on a fluoroscopic table; the instrumentation then was exteriorized with the use of a local anesthesia (lidocaine 2%). Lidocaine was also used to isolate either the right carotid or the right brachial artery for catheterization with a 6F guide catheter. With the use of fluoroscopic guidance, a Judkins angiographic catheter was placed in the coronary ostium of the instrumented artery. Placement of the catheter in the ostium was verified by injection of radiopaque contrast dye. Artery patency was verified by continuous monitoring of coronary blood flow. A small catheter made of PE10 tubing was inserted through the Judkins catheter into the coronary artery for intracoronary administration of pharmacological agents and measurement of coronary arterial pressure. Supplemental doses of ketamine (3-5 mg/kg i.m.) were administered throughout the duration of the protocol. At the end of the experiments, the acutely implanted catheter was removed, the carotid or brachial artery repaired, and the incision closed.
During the experiments, heart rate was held constant by atrial pacing, and doses of ACH (0.01, 0.05, 0.5, and 1.0 ,tg/kg) were administered through the coronary catheter. At least a 15-minute hiatus was allowed between each injection, and the responses were compared with a saline injection. The 0.5 ,ug/kg dose of ACH was used for further studies, because it was the largest concentration of drug that would not induce systemic effects. On separate days, the dose of 0.5 gg/kg was repeated after the administration of ,B- Table 1 shows the effects of intracoronary ACH in baboons. With heart rate held constant, intracoronary ACH (0.01 gg/kg) elicited only an increase in coronary blood flow ( Figure 1 ) and a decrease in coronary resistance. The higher doses of ACH induced a biphasic response, that is, intense vasoconstriction followed by vasodilation (Figure 2 ). There was a dose-related decrease in mean coronary blood flow and increase in late diastolic coronary resistance during the initial response to ACH (Figure 1) , and a dose-related decrease in late diastolic coronary resistance and increase in mean coronary blood flow during the late responses to ACH. Intracoronary ACH (0.5 ,ug/kg) induced intense initial coronary vasoconstriction (i.e., coronary blood flow fell by 82+4%), with maximal vasoconstriction at 10±1 seconds, and a later vasodilation (i.e., coronary blood flow rose by 121±12%), which was maximal at 23±2 seconds. The time required for the coronary response to return to baseline was 109±13 seconds. Regional myocardial function was measured during the injection of intracoronary ACH (0.5 gg/kg) in three baboons. In these experiments, the fall in late diastolic coronary blood flow preceded any reduction in regional myocardial function ( Figure 3 ). Regional myocardial function fell at a later time, clearly after blood flow was already reduced (Figure 4 ). In three of the baboons, coronary arterial stenoses were induced by inflation of the hydraulic occluder to mimic the ACH response ( Figure 5 Effects of Intrailiac Acetylcholine in Baboons Figure 6 shows the effects of intrailiac ACH in baboons. ACH at doses of 0.05, 0.5, 1.0, and 2.5 jig/kg administered locally through a catheter in the terminal aorta induced only vasodilation in the iliac circulation. Baseline values for iliac blood flow varied from 102± 10 to 115 of left circumflex coronary artery diameter. Initially. coronary diameter fell insignificantly but rose during the later phase (p<O.O5) by 11+2%. Discussion Cholinergic control of the coronary circulation has been the subject of intense controversy. Initially, the controversy involved differences in results from studies in canine coronary vessels; that is, both coronary vasodilation and vasoconstriction were observed in 
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.A L-in a variety of isolated vessel preparations. Accordingly, isolated vessels with endothelium inadvertently removed would respond differently to ACH than would vessels with endothelium intact. The major finding of the present investigation is that ACH elicits both primary vasoconstriction and primary vasodilation in the baboon, which can be blocked completely by atropine. Coronary blood flow almost ceased at the higher doses without a significant change in heart rate and arterial pressure. This response was followed by a transient vasodilation during which blood flow rose above baseline. It could not be ascertained whether the secondary increase in blood flow was a direct effect of ACH on endothelium or was similar to a reactive hyperemic response. A very similar pattern could be elicited in the same animals during the hyperemic phase after release from a stenosis, which mimicked the constriction induced by ACH ( Figure 5 ).
A potent vasoconstrictor response to ACH was observed at the moderate to higher doses in the coronary circulation. However, at the lowest dose, only coronary vasodilation was observed. In the iliac bed of the baboon, only vasodilation was observed with ACH at any dose studied. These differences in response to the higher doses in the coronary and iliac circulations and the differences between the higher and lower doses in the coronary circulation may reconcile some of the discrepancies reported by prior studies. Prior studies in anesthetized primates have reported both vasoconstriction3"1',17 and vasodilation,3,4"11 and prior studies in humans without atherosclerosis have also reported both vasoconstriction2,9,10,12-16 and vasodilation.6-9,10,12 It is conceivable that some of these differences among prior studies in primates, including humans, could be attributed to the dual action of ACH observed in the present study, as well as to the dose of ACH used. Most of the prior work in the field of endothelial vascular control has concentrated on large conductance vessels.5,24,25 More recently, increasing evidence suggests that endothelial mediated vasodilation also plays an important role in regulating resistance vessel caliber. [25] [26] [27] [28] [29] Assuming that ACH vasodilation is mediated by endothelial mechanisms, the results of the current study suggest that in primates, endothelial control of resistance coronary vessels, as opposed to peripheral vessels in the limb, can be overpowered by direct vasoconstrictor effects of ACH at increasing concentrations. The recent study by Newman et al10 also clearly demonstrates the importance of ACH concentration in determining whether coronary vasodilation or vasoconstriction is observed in humans.
When the effects of any intervention on the coronary circulation are examined, it is important to know if the changes in coronary blood flow are primary or secondary to changes in myocardial oxygen demands. The major determinants of myocardial oxygen consumption are heart rate, LV contractility, and afterload. Major changes in these parameters were not observed with ACH in the present investigation. However, it was considered that a local change in myocardial contractility could be missed by the measurements of global LV pressure and LV dP/dt. Accordingly, in a subset of animals, regional myocardial function was measured in the distribution of the coronary artery receiving the ACH. In all experiments, it was demonstrated clearly that coronary constriction occurred before the decrease in regional function. These two observations -that the initial ACH vasoconstriction essentially shut off coronary blood flow and that the decrease in coronary blood flow clearly preceded any decreases in regional ventricular function -indicate that the coronary vasoconstrictor effects were primary and not simply secondary to changes in myocardial oxygen demand.
Part of the controversy regarding the effects of ACH in the coronary circulation is due to differences in species studied. As mentioned above and confirmed in the present study only, coronary vasodilation is observed in normal canine coronary vessels with intact endothelium.145"1 However, in the conscious calf, both early vasoconstriction and later vasodilation were observed. In comparison with studies in the baboon, the vasoconstrictor phase in the calf was more transient, and the vasodilator phase was more intense and prolonged. A pattern intermediate between calf and baboon was recently observed in the coronary circulation of the pig. 30 It is interesting to speculate that different subtypes of muscarinic receptors, which have been shown to be involved in mediating responses to ACH,3' may vary among species and in different beds within a species and could be responsible for these qualitative differences.
In several studies in normal human subjects29"15 and in isolated vessel experiments,1314,16 ACH has been shown to constrict large coronary arteries. It was not determined in the present investigation whether ACH exerts its vasoconstrictor effects at the level of the small resistance vessels or at the level of larger coronary arteries. However, in selected instances, intracoronary injections of ACH were flushed with contrast media instead of saline, and no vasoconstriction of the larger coronary arteries was observed fluoroscopically. Although coronary dimensions were not quantitated, spasm of the large coronary arteries sufficient to reduce blood flow by an average of 82% was not observed. Furthermore, in a subset of calves studied, large coronary artery diameters were measured. In these experiments, only slight initial vasoconstriction was observed, followed by prolonged and more intense later vasodilation. The trivial vasoconstriction of the large coronary arteries occurred in the face of intense resistance vessel constriction, which in turn preceded any change in regional function in the portion of the left ventricle supplied by the coronary artery in which ACH was injected.
In summary, the extent to which ACH induces vasodilation or vasoconstriction depends not only on whether endothelium is intact, but also on the spe-cies, ACH concentration, and vascular bed being studied. The primary action of ACH in the baboon was constriction in the coronary bed at higher doses and vasodilation at lower doses. This might be explained by an endothelial mediated vasodilation, which is revealed at lower doses but is overpowered by a direct smooth muscle vasoconstrictor effect at higher concentrations. This dual coronary vascular action of ACH may help reconcile some of the controversy in this field.
